Skip to main content
Premium Trial:

Request an Annual Quote

Judge Triples Damages in Third Wave s Patent-Infringement Suit Against Stratagene

NEW YORK, Dec. 19 (GenomeWeb News) - Third Wave Technologies said today that a federal judge overseeing its patent infringement suit against Stratagene has tripled the damages awarded to $15.9 million and ruled that Stratagene must pay Third Wave's attorney fees.

 

In September, a federal court ruled that Stratagene infringed two patents covering Third Wave's Invader technology.

 

Later that month, the court found Stratagene liable for willful patent infringement and awarded Third Wave $5.3 million in damages. The court also prohibited Stratagene from making, selling, or offering to sell its FullVelocity QPCR and QRT-PCR products.

 

Third Wave said today that it "sought the additional damages, given the willful infringement verdict."

 

Kevin Conroy, president and CEO of Third Wave, said in a statement today that the increase in damages "will send a strong signal to others who would infringe Third Wave's unique and valuable intellectual property."

 

Stratagene officials were not immediately available for comment.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.